Kraft Heinz Announces Agreement to Sell B2B Powdered Cheese Business to Kerry Group
Transaction Expected to Close in the Second Half of 2022
The transaction involves the divestiture of Kraft Heinz’s B2B powdered cheese products, which are sold through the Company’s Ingredients business. This divestiture includes the
The divestiture of the B2B powdered cheese business reflects the Company's ongoing and active portfolio optimization.
We are driving transformation at
Kerry is the world's leading taste and nutrition partner for the food, beverage and pharmaceutical markets. We innovate with our customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. Our leading consumer insights, global RD&A team of 1,100+ food scientists and extensive global footprint enable us to solve our customers' complex challenges with differentiated solutions. At Kerry, we are driven to be our customers' most valued partner, creating a world of sustainable nutrition, and to reach over 2 billion consumers with sustainable nutrition solutions by 2030. For more information, visit www.kerry.com.
This press release contains a number of forward-looking statements. Words such as “close,” “continue," “create,” “expect,” “have,” “help,” “intend,” “involve,” “operate,” “reflect,” “transfer,” “will,” and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements about the assets included in the proposed sale, that the sale is subject to customary closing conditions including regulatory clearances, future operation of manufacturing facilities, treatment of affected employees, the timing of closing, expected benefits of the proposed sale, impacts of the proposed sale on the Company’s business, financial results, opportunities, and future plans, and other statements that are not historical facts, each of which is based on the Company’s current beliefs, expectations, estimates, and projections. These forward-looking statements are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond the Company’s control, which could cause actual results to differ materially from those indicated in the forward-looking statements. Those factors include, but are not limited to, the timing of or failure to obtain necessary regulatory approvals or to satisfy any other conditions of the sale, the Company’s ability to achieve intended benefits of the sale, the expected costs of the transaction, the success of business transitions, and the risk factors set forth in the Company’s filings with the